| CAS ID: | 11004-65-2 |
| Molecular Formula: | C23H46N6O13 |
| Molecular Weight: | 614.7 g/mol |
| Monoisotopic Mass: | 614.3123 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | NEOBIOTIC | Mycifradin | Fradiomycin Sulfate | NEOMYCIN B | NEO-RX | NEO-FRADIN | Biosol | NEOMYCIN SULFATE | FRAMYCETIN | Neomycin Trisulfate Trihydrate | Neomycin Trisulfate Hydrate |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1 | See All |
| InChI Key: | PGBHMTALBVVCIT-VCIWKGPPSA-N | |
| Smiles: | NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01097811 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Unknown |
| First Received | April 2, 2010 | Last Verified | April 28, 2010 |
| Sponsor | UPECLIN HC FM Botucatu Unesp | ||
| PubChem: | 8378 |
| ChEMBL: | CHEMBL184618 |